Terran is in the process of creating an extensive array of revolutionary treatments and technologies to improve the lives of individuals afflicted with neurological and mental disorders. Terran, a biotechnology platform enterprise, is developing an array of treatments and technologies for individuals suffering from neurological and psychiatric disorders. With the support of various investors in life sciences and technology, Terran has established a technology-driven drug development platform focused on the central nervous system (CNS) and is swiftly progressing with a number of advanced-stage assets, including innovative therapeutics based on psychedelics.